HBV Mutation Detail Information

> G1764A Search Result


Mutation Information
Mutation Site G1764A
Mutation Type Nucleotide level
Gene/Protein/Region Type BCP
Combined Mutation bcp.G1764A+bcp.A1762T
Genotype/Subtype C
Viral Reference AB981580
Relevant Drug pegylated interferon(PEG-IFN)
Country Thailand
Literature Information
PubMed PMID 31359359
Disease Chronic hepatitis B
Published Year 2019
Journal Virus genes
Title Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.
Author Chuaypen N,Payungporn S,Poovorawan K,Chotiyaputta W,Piratvisuth T,Tangkijvanich P
Evidence Based on NGS, the prevalence of T1753V (T1753C/A/G) and A1762T/G1764A variants were significantly lower in responders compared to non-responders (8.3% vs. 51.4%, P = 0.009 and 33.3% vs. 68.6%, P = 0.032, respectively).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation